跳至主要内容
临床试验/NCT06598865
NCT06598865暂停不适用

Comparative Effectiveness on Glycemic Balance of a Non-pharmacological Treatment, Adapted Physical Activity (APA), Either Supervised by a Qualified APA Instructor or Unsupervised in Autonomy, in Individuals With Inadequately Controlled Type 2 Diabetes, Under Diet Alone or Non-insulin Treatment.

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年2月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
120
试验地点
1
主要终点
Evaluate the efficacy of a 3-month re-training program, by comparing glycemic averages (measured for 10 consecutive days at 3 months, by a continuous glucose monitoring device (CGM) between experimental group (APA) vs control group.

研究概览

简要总结

Comparative effectiveness on glycemic balance of a non-pharmacological treatment, Adapted Physical Activity (APA), either supervised by a qualified APA instructor or unsupervised in autonomy, in individuals with inadequately controlled Type 2 Diabetes, under diet alone or non-insulin treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 67 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient who has given consent to participate in the study and has signed an informed consent form.
  • •Patient aged 18 to 67 years
  • •Patient diagnosed with type 2 diabetes
  • •Patient newly diagnosed or on non-insulin treatment (metformin +/- DPP4 inhibitor, GLP1 analogue +/- SGLT2 inhibitor) for whom it is considered to initiate or intensify antidiabetic treatment by introducing a new therapeutic class.
  • •Patient insufficiently controlled (> 1.30 g/L fasting blood glucose measured in the laboratory twice a few days apart in a city laboratory)
  • •Patient with good venous access.
  • •Patient capable of engaging in regular physical activity
  • •Patient who has undergone a coronary artery disease screening test in the year prior to inclusion according to the new recommendations of an expert consensus.
  • •Patient agrees to wear a FitBit Charge 6 bracelet for the entire duration of the study, including the run-in period, and agrees to recharge it and transmit the data.

排除标准

  • •Patient diagnosed with type 1 diabetes
  • •Patient treated with sulfonylureas
  • •Patient with a history of severe cardiovascular diseases (myocardial infarction, acute coronary syndrome, or stroke in the past year)
  • •Patient presenting a medical contraindication to performing a physical activity session (uncontrolled resting hypertension, i.e., systolic blood pressure > 160 mmHg and/or diastolic blood pressure > 100 mmHg, unstable coronary artery disease, heart failure, severe proliferative or non-proliferative evolving retinopathy (unstabilized), or having undergone recent surgical laser treatment of the eye, plantar perforating ulcer, disabling osteoarthritis of the lower limbs, respiratory failure, severe renal impairment, liver failure, severe dysautonomia, i.e., risk of chronotropic insufficiency during exercise, peripheral neuropathy)
  • •Patient with a history of severe hypoglycemia in the 6 months prior to entering the study and/or not feeling their hypoglycemia at all
  • •Patient with an IPAQ score in the high category
  • •Patient with a known latex allergy
  • •Patient with morbid obesity (BMI > 40 kg/m²)
  • •Other conditions that may interfere with glycemic variation: particularly the use of corticosteroids during the study
  • •Patient treated with beta-blockers or calcium channel blockers with negative chronotropic action (such as isoptin)
  • •Breastfeeding woman
  • •Pregnant woman* or wishing to become pregnant

研究组 & 干预措施

control

No Intervention

after initial APA training, patients will be asked to implement APA sessions on their own for the duration of the study. They will then be asked to return to the investigating center for a visit at 3 months (Visit 3) to assess the effect of the APA carried out during this period.

experimental

Experimental

after initial APA training, patients will receive regular support from an APA teacher, and will be asked to carry out 3 APA sessions a week, if possible in a Sport-Santé centre close to their home, for the duration of the study. The content of additional APA sessions (up to 2 additional sessions per week) can be discussed with the APA teacher.

They will also be asked to return to the investigating center for a visit at 3 months (Visit 3) to assess the effect of the APA carried out during this period.

干预措施: adapted physical activity (Other)

结局指标

主要结局

Evaluate the efficacy of a 3-month re-training program, by comparing glycemic averages (measured for 10 consecutive days at 3 months, by a continuous glucose monitoring device (CGM) between experimental group (APA) vs control group.

时间窗: 10 days after 3-month re-training program

Measurement of glucose by CGM

次要结局

未报告次要终点

研究者

发起方
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparative Effectiveness of Prescribed Adapted... | 临床试验